LU78997A1 - PROCEDURE FOR INDUCING IMMUNOLOGICAL TOLERANCE - Google Patents
PROCEDURE FOR INDUCING IMMUNOLOGICAL TOLERANCEInfo
- Publication number
- LU78997A1 LU78997A1 LU78997A LU78997A LU78997A1 LU 78997 A1 LU78997 A1 LU 78997A1 LU 78997 A LU78997 A LU 78997A LU 78997 A LU78997 A LU 78997A LU 78997 A1 LU78997 A1 LU 78997A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- procedure
- immunological tolerance
- inducing immunological
- inducing
- tolerance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S524/00—Synthetic resins or natural rubbers -- part of the class 520 series
- Y10S524/90—Antigen-antibody
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/764,586 US4191668A (en) | 1977-02-03 | 1977-02-03 | Induction of immunological tolerance |
Publications (1)
Publication Number | Publication Date |
---|---|
LU78997A1 true LU78997A1 (en) | 1978-06-21 |
Family
ID=25071153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU78997A LU78997A1 (en) | 1977-02-03 | 1978-02-03 | PROCEDURE FOR INDUCING IMMUNOLOGICAL TOLERANCE |
Country Status (17)
Country | Link |
---|---|
US (1) | US4191668A (en) |
JP (1) | JPS53121943A (en) |
AU (1) | AU515181B2 (en) |
BE (1) | BE863656A (en) |
CA (1) | CA1118347A (en) |
CH (1) | CH644521A5 (en) |
DE (1) | DE2804457C2 (en) |
DK (1) | DK155174C (en) |
FI (1) | FI780312A (en) |
FR (1) | FR2379287A1 (en) |
GB (1) | GB1599454A (en) |
LU (1) | LU78997A1 (en) |
MX (1) | MX6266E (en) |
NL (1) | NL7801220A (en) |
NO (1) | NO153419C (en) |
SE (1) | SE464616B (en) |
ZA (1) | ZA78613B (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4220565A (en) * | 1979-01-18 | 1980-09-02 | Scripps Clinic & Research Foundation | Immunochemical conjugates: method and composition |
US4276206A (en) * | 1979-01-18 | 1981-06-30 | Scripps Clinic & Research Foundation | Immunochemical conjugates: method and composition |
US4253995A (en) * | 1980-02-11 | 1981-03-03 | Scripps Clinic And Research Foundation | Immunochemical conjugates: method and composition |
US4253996A (en) * | 1980-02-13 | 1981-03-03 | Scripps Clinic And Research Foundation | Immunochemical conjugates: method and composition |
DE3114362C2 (en) * | 1980-04-11 | 1983-08-18 | Toshiyuki Prof. Nara Hamaoka | Process for producing an antibody or antiserum, use of this process for obtaining mammalian cells which are capable of producing such an antibody, and use of the antibody or antiserum produced in this way for immunoassay |
EP0077158A1 (en) * | 1981-10-09 | 1983-04-20 | Beecham Group Plc | Modified allergens |
US5370871A (en) * | 1983-01-24 | 1994-12-06 | The Johns Hopkins University | Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry |
US6022544A (en) | 1983-01-24 | 2000-02-08 | The John Hopkins University | Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry |
US5126131A (en) * | 1983-01-24 | 1992-06-30 | The Johns Hopkins University | Therapeutic suppression of specific immune responses by administration of antigen-competitive conjugates. |
US4950713A (en) * | 1986-05-30 | 1990-08-21 | La Jolla Pharmaceutical Company | Conjugates of D-glutamic acid: D-lysine copolymer and certain biochemicals |
US4950469A (en) * | 1986-05-30 | 1990-08-21 | La Jolla Pharmaceutical Company | D-GL conjugate therapy |
US5017648A (en) * | 1986-05-30 | 1991-05-21 | La Jolla Pharmaceutical Company | D-GL conjugate therapy |
CA1309558C (en) * | 1986-05-30 | 1992-10-27 | Quidel | D-gl conjugate therapy |
US5162515A (en) * | 1990-01-16 | 1992-11-10 | La Jolla Pharmaceutical Company | Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus |
US5552391A (en) * | 1990-01-16 | 1996-09-03 | La Jolla Pharmaceutical Company | Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
US5391785A (en) * | 1990-01-16 | 1995-02-21 | La Jolla Pharmaceutial Company | Intermediates for providing functional groups on the 5' end of oligonucleotides |
US5268454A (en) | 1991-02-08 | 1993-12-07 | La Jolla Pharmaceutical Company | Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier |
JP2899111B2 (en) * | 1991-07-15 | 1999-06-02 | ラ ホヤ ファーマシューティカル カンパニー | Modified phosphite intermediates for providing functional groups to the 5 'end of oligonucleotides |
KR100361933B1 (en) * | 1993-09-08 | 2003-02-14 | 라 졸라 파마슈티칼 컴파니 | Chemically defined nonpolymeric bonds form the platform molecule and its conjugate |
US8071737B2 (en) | 1995-05-04 | 2011-12-06 | Glead Sciences, Inc. | Nucleic acid ligand complexes |
US6410775B1 (en) * | 1995-06-07 | 2002-06-25 | La Jolla Pharmaceutical Company | APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies |
US5874409A (en) | 1995-06-07 | 1999-02-23 | La Jolla Pharmaceutical Company | APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies |
US6858210B1 (en) | 1998-06-09 | 2005-02-22 | La Jolla Pharmaceutical Co. | Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same |
US6399578B1 (en) * | 1998-12-09 | 2002-06-04 | La Jolla Pharmaceutical Company | Conjugates comprising galactose α1,3 galactosyl epitopes and methods of using same |
US6458953B1 (en) | 1998-12-09 | 2002-10-01 | La Jolla Pharmaceutical Company | Valency platform molecules comprising carbamate linkages |
US7084256B2 (en) * | 1999-09-24 | 2006-08-01 | Large Scale Biology Corporation | Self antigen vaccines for treating B cell lymphomas and other cancers |
US20030039659A1 (en) * | 1999-09-24 | 2003-02-27 | Mccormick Alison A. | Self antigen vaccines for treating B cell lymphomas and other cancers |
EP1292337A2 (en) | 2000-06-08 | 2003-03-19 | La Jolla Pharmaceutical | Multivalent platform molecules comprising high molecular weight polyethylene oxide |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3825525A (en) * | 1969-08-06 | 1974-07-23 | Beecham Group Ltd | Allergens reacted with carbodiimides |
GB1282163A (en) * | 1969-08-06 | 1972-07-19 | Beecham Group Ltd | Modified allergens and a process for their preparation |
-
1977
- 1977-02-03 US US05/764,586 patent/US4191668A/en not_active Expired - Lifetime
-
1978
- 1978-01-31 CA CA000295952A patent/CA1118347A/en not_active Expired
- 1978-01-31 FI FI780312A patent/FI780312A/en not_active Application Discontinuation
- 1978-02-01 ZA ZA00780613A patent/ZA78613B/en unknown
- 1978-02-02 DE DE2804457A patent/DE2804457C2/en not_active Expired
- 1978-02-02 NL NL7801220A patent/NL7801220A/en not_active Application Discontinuation
- 1978-02-02 JP JP1105378A patent/JPS53121943A/en active Granted
- 1978-02-02 DK DK049178A patent/DK155174C/en not_active IP Right Cessation
- 1978-02-02 GB GB4310/78A patent/GB1599454A/en not_active Expired
- 1978-02-02 SE SE7801268A patent/SE464616B/en unknown
- 1978-02-02 NO NO780366A patent/NO153419C/en unknown
- 1978-02-03 CH CH124078A patent/CH644521A5/en not_active IP Right Cessation
- 1978-02-03 MX MX786822U patent/MX6266E/en unknown
- 1978-02-03 BE BE184908A patent/BE863656A/en not_active IP Right Cessation
- 1978-02-03 FR FR7803063A patent/FR2379287A1/en active Granted
- 1978-02-03 LU LU78997A patent/LU78997A1/en unknown
- 1978-02-05 AU AU32933/78A patent/AU515181B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
NO153419B (en) | 1985-12-09 |
SE7801268L (en) | 1978-08-04 |
JPH0428689B2 (en) | 1992-05-15 |
DK155174B (en) | 1989-02-27 |
JPS53121943A (en) | 1978-10-24 |
NO780366L (en) | 1978-08-04 |
DK49178A (en) | 1978-08-04 |
FI780312A (en) | 1978-08-04 |
BE863656A (en) | 1978-05-29 |
DK155174C (en) | 1989-07-10 |
DE2804457C2 (en) | 1984-04-12 |
FR2379287A1 (en) | 1978-09-01 |
AU515181B2 (en) | 1981-03-19 |
MX6266E (en) | 1985-02-27 |
FR2379287B1 (en) | 1980-08-29 |
NO153419C (en) | 1986-03-19 |
US4191668A (en) | 1980-03-04 |
CH644521A5 (en) | 1984-08-15 |
NL7801220A (en) | 1978-08-07 |
ZA78613B (en) | 1978-12-27 |
DE2804457A1 (en) | 1978-08-10 |
SE464616B (en) | 1991-05-27 |
AU3293378A (en) | 1979-08-09 |
GB1599454A (en) | 1981-10-07 |
CA1118347A (en) | 1982-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU78997A1 (en) | PROCEDURE FOR INDUCING IMMUNOLOGICAL TOLERANCE | |
FR2439801B1 (en) | PROCESS FOR THE PREPARATION OF POLYCARBONATES | |
SE7809240L (en) | POLYESTRAR MODIFIER | |
SE7803475L (en) | HALLARE FOR PASAR | |
SE7803476L (en) | HALLARE FOR PASAR | |
SE7802923L (en) | PROCEDURE FOR IMMUNOLOGICAL DETERMINATION | |
BE873136A (en) | PROCESS FOR THE PREPARATION OF VINCADIFFORMIN | |
SE7805258L (en) | HEADLIGHT | |
SE7712754L (en) | BERVEGG FOR RORSLINGOR | |
AT364318B (en) | COMPONENT SYSTEM | |
BE857244A (en) | PROCESS FOR THE PREPARATION OF 3-CHLOROCEPHALOSPORINS | |
BE866490A (en) | DOSAGE PROCEDURE | |
BE866602A (en) | CAM ARRANGEMENT | |
FR2345454A1 (en) | PROCESS FOR THE PREPARATION OF 3-HALOMETHYLCEPHEMES | |
ES244818Y (en) | SELF-RETAINED FIXING DEVICE | |
SE7807813L (en) | PLATE FOR PLATE CONDENSER | |
BR7803504A (en) | DEVICE FOR PROCESSING FOODSTUFFS | |
FI780216A (en) | ANORDINATION FOR FAIRGTELEVISIONSMOTTAGARE | |
RO71278A (en) | PROCEDURE FOR THE PROCESS HYDROFORMATION PROCESSING DISTILLATION PROCESSING | |
BE868117A (en) | DIMERIZATION PROCESS | |
BE870778A (en) | VERTICAL STEAM SEPARATOR-SUPERHEATER | |
BE870104A (en) | PROCESS FOR THE PREPARATION OF 2-CHLOROSULFINYL-AZETIDIN-4-ONES | |
BE866904A (en) | PROCESS FOR THE PREPARATION OF 3-BROMOPHTALIDE | |
BE850632R (en) | PROCESS FOR THE PREPARATION OF PARA-ALKYLPHENOLS | |
RO76088A (en) | PROCESS FOR THE PREPARATION OF TIOCARBAMATES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TP | Transfer of rights |
Free format text: 860903 SCRIPPS CLINIC & RESEARCH FOUNDATION LA JOLLA |